Measurement of fecal lipocalin-2 (Lcn-2) levels in patients with relapsing-remitting multiple sclerosis (RRMS) and in experimental autoimmune encephalomyelitis (EAE) mouse models. Here, LCN2 is linked to relapsing-remitting multiple sclerosis.